|
MechanismCav2.1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date01 Jan 1992 |
|
|
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.United States |
First Approval Date23 Jun 2005 |
100 Clinical Results associated with ADOH B.V
0 Patents (Medical) associated with ADOH B.V
100 Deals associated with ADOH B.V
100 Translational Medicine associated with ADOH B.V